|
Vascular Endothelial Growth Factor Measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.
|
21757650 |
2011 |
|
Vascular Endothelial Growth Factor Measurement
|
|
0.800 |
GeneticVariation
|
GWASDB |
Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.
|
21757650 |
2011 |
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.030 |
GeneticVariation
|
BEFREE |
Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM).
|
30579324 |
2019 |
|
Metabolic Syndrome X
|
|
0.030 |
GeneticVariation
|
BEFREE |
We have investigated the association between 4 cis- and trans-genetic variants (rs6921438, rs4416670, rs6993770 and rs10738760) of the vascular endothelial growth factor (VEGF) gene and metabolic syndrome (MetS) and its individual components in an Iranian population.
|
29891039 |
2018 |
|
Metabolic Syndrome X
|
|
0.030 |
GeneticVariation
|
BEFREE |
The aim of this study was to investigate the role of the association between the dietary intake of iron, copper, zinc, manganese, selenium, and iodine (assessed by 24 recall) with vascular endothelial growth factor variants (rs6921438, rs4416670, rs6993770, and rs10738760), on the risk of MetS.
|
30367505 |
2018 |
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.030 |
GeneticVariation
|
BEFREE |
In conclusion, VEGF-related SNPs rs10738760 and rs6921438 are not associated with DR in our group of Slovenian patients (Caucasians) with T2DM.
|
29055125 |
2017 |
|
Metabolic Syndrome X
|
|
0.030 |
GeneticVariation
|
BEFREE |
Therefore the aim of present study was to explore the association of serum VEGF level and its associated genetic-polymorphism, rs10738760 (A>G) at 9p24.2, in 850 subjects with/without MetS.
|
27984191 |
2017 |
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.030 |
GeneticVariation
|
BEFREE |
Despite having adequate statistical power, we did not find any significant effects of rs6921438 or rs10738760 on diabetic microvascular complications or the variation in related traits in T2D patients.In spite of their impact on the variance in circulating VEGF, we did not find any association between SNPs rs6921438 and rs10738760, and the risk of T2D, diabetic nephropathy or retinopathy.
|
23405237 |
2013 |
|
Proliferative diabetic retinopathy
|
|
0.010 |
GeneticVariation
|
BEFREE |
Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM).
|
30579324 |
2019 |
|
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS
|
|
0.010 |
GeneticVariation
|
BEFREE |
However, we observed no association between AA genotype of rs6921438 nor between rs10738760 variants and PDR, indicating that the two polymorphisms are not genetic risk factors for PDR.
|
30579324 |
2019 |
|
Diabetic Retinopathy
|
|
0.010 |
GeneticVariation
|
BEFREE |
Logistic regression analysis showed that rs6921438 and rs10738760 were not independent genetic risk factors for DR in the co-dominant model adjusted for the above-mentioned clinical and laboratory data.
|
29055125 |
2017 |
|
Graves Disease
|
|
0.010 |
GeneticVariation
|
BEFREE |
Whereas rs10738760 appeared specific to GD and FT3 production after six months of treatment, rs6921438 and rs4416670 were implicated in the risk for GD.
|
26955881 |
2016 |